Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Apr;31(4):1261-7.
doi: 10.1002/1521-4141(200104)31:4<1261::AID-IMMU1261gt;3.0.CO;2-H.

Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice

Affiliations
Free PMC article

Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice

F R Donís-Hernández et al. Eur J Immunol. 2001 Apr.
Free PMC article

Abstract

Analysis of expression of CD38, CD45R (B220), IgM and IgD on splenic B lymphocytes from mice of different ages demonstrated CD38 on both immature (B220(+), BCR(-)) and mature (B220(+), BCR(+)) B lymphocytes. Similarly, CD38 is expressed as early as B220 on the surface of progenitor B cells in the bone marrow. In spite of expressing of CD38 and IgM, neonatal B cells, in contrast to the adult, failed to proliferate to either anti-CD38 or anti-IgM cross-linking when IL-4 was present. They did, however, respond to LPS and anti-CD40, and by 2 weeks of age they began to respond to anti-CD38 and anti-IgM, reaching adult B cell levels by 4 weeks. Although the distribution of CD38 on adult B cells from most different lymphoid compartments was broadly similar, significantly higher levels of CD38 were expressed on peritoneal B lymphocytes. A detailed analysis, using IgM / IgD ratio and staining with anti-CD5 confirmed that B1 lymphocytes were expressing a high level of CD38. Interestingly, both immature B cells and peritoneal B1 lymphocytes were unresponsive to anti-CD38. However, they were activated by LPS or anti-CD40.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Ontogeny of the expression of CD38 in the spleen. Splenic lymphocytes from BALB / c mice at different ages were stained with B220-FITC (A), anti-IgM-FITC (B) or anti-IgD-FITC (C) and counter-stained with anti-CD38-PE. IC: isotype control staining for the pairs used in each combination; NB: newborn mice; 1 – 8W, 1 – 8 weeks old.
Fig. 2
Fig. 2
Expression of CD38 in bone marrow from adult mice. Bone marrow cells from 8-week-old BALB / c mice were stained with B220-FITC and anti-CD38-PE for panel A; and anti-HSA-FITC, anti-IgM-FITC or anti-IgD-FITC and then counter-stained with B220-PE or anti-CD38-PE for panel B.
Fig. 3
Fig. 3
Immature B lymphocytes fail to proliferate to anti-CD38 stimulation. 106-MACS purified splenic B lymphocytes from BALB / c mice at different ages were stimulated with 50 μg / ml LPS, 10 μg / ml anti-mouse IgM (B7.6), 20 μg / ml anti-mouse CD38 (NIM-R5), or 10 μg / ml anti-mouse CD40 (1C10). All cultures contained 10 U / ml of recombinant mouse IL-4. The cultures were incubated for 72 h at 37 °C, 5 % CO2 and pulsed with [3H] thymidine during the last 4 h of culture. Results are shown as mean cpm plus standard deviation from four wells. This is a representative experiment of five done in the same manner and with similar results.
Fig. 4
Fig. 4
B lymphocytes from three strains of adult mice express and proliferate to anti-CD38 stimulation. Splenic lymphocytes from three strains of adult mice were stained with anti-B220-FITC / anti-CD38-PE (panel A). Purified B lymphocytes from spleen of each strain of mice were stimulated with 10 μg / ml anti-mouse IgM (B7.6), 20 μg / ml anti-mouse CD38 (NIM-R5), or 10 μg / ml anti-mouse CD40 (1C10). All cultures contained 10 U / ml of recombinant mouse IL-4. The cultures were incubated for 72 h at 37 °C, 5 % CO2 and pulsed with [3H] thymidine during the last 4 h of culture. Results are shown as mean cpm plus standard deviation from 4 wells (panel B). This is a representative experiments of five done in the same manner and with similar results.
Fig. 5
Fig. 5
Differential expression of CD38 on B lymphocytes from different lymphoid compartments. Total lymphocytes from spleen, peritoneal cavity, Peyer's patches and bone marrow were stained with FITC-anti-mouse CD38 (NIM-R5). Numbers in parentheses show the mean fluorescence intensity of the CD38+ cells.
Fig. 6
Fig. 6
B1 lymphocytes from peritoneal cavity express high levels of CD38 on their surface, but fail to proliferate to CD38 cross-linking. Lymphocytes from the peritoneal cavity were stained with anti-IgD-FITC / anti-IgM-PE, anti-CD38-biotin and then streptavidin-PerCP or with anti-CD38-FITC / anti-CD5-PE (panel A). Purified B lyphocytes from the peritoneal cavity or the spleen were stimulated with 50 μg / ml LPS, 10 μg / ml anti-mouse IgM (B7.6), 20 μg / ml anti-mouse CD38 (NIM-R5), or 10 μg / ml anti-mouse CD40 (1C10). All cultures contained 10 U / ml of recombinant mouse IL-4. The cultures were incubated for 72 h at 37 °C, 5 % CO2 and pulsed with [3H] thymidine during the last 4 h of culture. Results are shown are mean cpm plus standard deviation from 4 wells (panel B). This is a representative experiments of five done in the same manner and with similar results.

References

    1. Lund FE, Cockayne DA, Randall TD, Solvason N, Schuber F, Howard MC. CD38: a new paradigm in lymphocyte activation and signal transduction. Immunol. Rev. 1998;161:79–93. - PubMed
    1. Ferrero E, Saccucci F, Malavasi F. The making of a leukocyte receptor: origin, genes and regulation of human CD38 and related molecules. Chem. Immunol. 2000;75:1–19. - PubMed
    1. Campana D, Suzuki T, Todisco E, Kitanaka A. CD38 in hematopoiesis. Chem. Immunol. 2000;75:169–188. - PubMed
    1. Konopleva M, Rissling I, Andreeff M. CD38 in hematopoietic malignancies. Chem. Immunol. 2000;75:189–206. - PubMed
    1. Bofill M, Borthwick NJ. CD38 in health and disease. Chem. Immunol. 2000;75:218–234. - PubMed

Publication types

MeSH terms